---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013552"
form_type: "8-K"
ticker: "FOXO"
cik: "0001812360"
company_name: "FOXO TECHNOLOGIES INC."
filed_at: "2025-09-15T23:59:59+00:00"
generated_at: "2026-05-17T06:39:19.715442+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# FOXO acquires Vector BioSource for $500K cash, Series E shares, and warrants

## Summary
- Purchase price includes $500K cash, 60,000 Series E Preferred shares, and warrants for up to $2M common stock at 110% of pre-close price.
- Contingent earnout of up to 80,000 Series E shares if Vector achieves $4M qualifying revenue in year 2 after closing.
- Closing requires due diligence, final warrants/employment agreements, and 12-month budget with up to $1.2M funding.
- Sellers have limited right to repurchase shares at fair market value with a floor.

## SEC filing metadata
- accession: 0001493152-25-013552
- form_type: 8-K
- ticker: FOXO
- cik: 0001812360
- company_name: FOXO TECHNOLOGIES INC.
- filed_at: 2025-09-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812360/000149315225013552/0001493152-25-013552-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812360/000149315225013552/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013552
- JSON: https://secwatch.observer/filing/0001493152-25-013552.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013552.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.